Indications |
Oral As a haemostatic Adult: 10-30 mg tid. Injection As a haemostatic Adult: 10 mg daily by SC/IM inj. Alternatively, 25-100 mg daily by IV Inj or drip infusion. |
Adverse Reactions |
GI disturbances (oral); hypersensitivity. |
Mechanism of Actions |
Carbazochrome is an oxidation product of adrenaline (epinephrine). It has been used as a haemostatic agent. |
ATC Classification |
B02BX02 - carbazochrome ; Belongs to the class of other systemic hemostatics. Used in the treatment of hemorrhage. |
Available As |
|
Carbazochrome
Post Review about Carbazochrome Click here to cancel reply.
Carbazochrome Containing Brands
Carbazochrome is used in following diseases
Drug - Drug Interactions of Carbazochrome
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.